Atypical fibroxanthoma with regional lymph node metastasis: Report of a case and review of the literature

Archives of Dermatology

Volumn 146, Issue 12, 2010, Pages 1399-1404

  New, Douglas ^a   Bahrami, Soon ^a   Malone, Janine ^a   Callen, Jeffrey P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD99 ANTIGEN; COLLAGEN TYPE 1; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN; CYTOKERATIN MNF 116; PROTEIN; PROTEIN LN 2; PROTEIN P63; PROTEIN S 100; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

AGED; ANAMNESIS; ARTICLE; ATYPICAL FIBROXANTHOMA; CASE REPORT; CERVICAL LYMPHADENOPATHY; DISEASE COURSE; FIBROXANTHOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MANDIBLE; PRIORITY JOURNAL; SPINDLE CELL SARCOMA;

AGED, 80 AND OVER; BIOPSY; DIAGNOSIS, DIFFERENTIAL; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NECK; SKIN NEOPLASMS;

EID: 78650440832     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.206     Document Type: Article

References (20)

1. Mirza B, Weeclon D. Atypical fibroxanthoma: a clinicopathological study of 89 cases. Australas J Dermatol. 2005;46(4):235-238.
2. Gleason BC, Calder KB, Cibull TL, et al. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma. J Cutan Pathol 2009;36(5):543-547.
3. Helwig EB. Tumor seminar proceedings of the 18th annual tumor seminar of San Antonio Society of Pathologists, 1961: atypical fibroxanthoma. Tex J Med. 1963: 59(5):664-667.
4. Cooper JZ, Newman SR, Scott GA, Brown MD. Metastasizing atypical fibroxanthoma (cutaneous malignant histiocytoma): report of five cases. Dermatol Surg. 2005 31(2):221-225.
5. Muenster MR, Hoang MP. Left facial mass in an elderly man: metastasizing atypical fibroxanthoma of the skin. Arch Pathol Lab Med. 2006;130(5):735-736.
6. Helwig EB, May D. Atypical fibroxanthoma of the skin with metastasis. Cancer. 1986:57(2):368-376.
7. Jacobs DS, Edwards WD, Ye RC. Metastatic atypical fibroxanthoma of skin. Cancer. 1975:35(2):457-463.
8. Kargi E, Güngör E, Verdi M, et al. Atypical fibroxanthoma and metastasis to the lung. Plast Reconstr Surg. 2003;111(5):1760-1762.
9. Lum DJ, King AR. Peritoneal metastases from an atypical fibroxanthoma. Am J Surg Pathol. 2006;30(8):1041-1046.
10. Giuffrida TJ, Kligora CJ, Goldstein GD. Localized cutaneous metastases from an atypical fibroxanthoma. Dermatol Surg. 2004;30(12, pt 2):1561-1564.
11. Grosso M, Lentini M, Carrozza G, Catalano A. Metastatic atypical fibroxanthoma of skin. Pathol Res Pract. 1987;182(3):443-447.
12. Kemp JD, Stenn KS, Arons M, Fischer J. Metastasizing atypical fibroxanthoma: coexistence with chronic lymphocytic leukemia. Arch Dermatol. 1978;114(10): 1533-1535.
13. Dahl I. Atypical fibroxanthoma of the skin: aclinico-pathological study of 57 cases. Acta Pathol Microbiol Scand A. 1976;84(2):183-197.
14. Sankar NM, Pang KS, Thiruchelvam T, Meldrum-Hanna WG. Metastasis from atypical fibroxanthoma of skin. Med J Aust. 1998;168(8):418-419.
15. Ang GC, Roenigk RK, Otley CC, Kim Phillips P, Weaver AL. More than 2 decades of treating atypical fibroxanthoma at mayo clinic: what have we learned from 91 patients? Dermatol Surg. 2009;35(5):765-772.
16. Lazova R, Moynes R, May D, Scott G. LN-2 (CD74): a marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma. Cancer. 1997;79(11): 2115-2124.
17. Monteagudo C, Calduch L, Navarro S, Joan-Figueroa A, Llombart-Bosch A. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. Am J Clin Pathol. 2002;117(1):126-131.
18. Mathew RA, Schlauder SM, Calder KB, Morgan MB. CD117 immunoreactivity in atypical fibroxanthoma. Am J Dermatopathol. 2008:30(1):34-36.
19. Hultgren TL, DiMaio DJ. Immunohistochemical staining of CD10 in atypical fibroxanthomas. J Cutan Pathol. 2007;34(5):415-419.
20. de Feraudy S, Mar N, McCalmont TH. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma. Am J Surg Pathol. 2008: 32(8):11'11-1122.